Navigation Links
Experimental Vaccine Shows Promise for Ovarian Cancer
Date:4/7/2013

signs of improvement in 19 out of 31 patients. All 19 developed an anti-tumor immune response. Of those, eight had no measurable disease and are on maintenance vaccine therapy. And one of the eight, whose cancer recurred several times, has been in remission for 45 months, the study authors said.

The researchers added a further step for 11 patients who responded to the vaccine treatment but still had residual disease. They removed immune cells called T cells from patients' blood, stimulated and expanded the cells in the laboratory, and then reinjected them into the patients. Of the 11 patients, seven had stable disease and one had a complete response, the investigators found.

Both treatments were given in conjunction with bevacizumab, a drug that controls blood vessel growth.

Side effects were mild, Kandalaft said. As for cost, she believes that it will be cheaper than some existing cancer drugs that cost $75,000 to $100,000 for a regimen.

The next step is to continue research into the treatment, she added.

A second study being presented at the meeting focused on an experimental drug to treat women whose ovarian cancer has developed resistance to platinum-based chemotherapy. The cancer inevitably gets worse in patients when chemotherapy no longer works.

The drug, being developed by the Genentech pharmaceutical company, is designed to deliver a kind of poison to cancer cells without being too toxic to the patient.

Researchers led by Dr. Joyce Liu, of the Dana-Farber Cancer Institute and Harvard Medical School in Boston, found that five patients out of 44 responded at least partially to the treatment. However, many who took the treatment suffered from several types of side effects.

A researcher who was not involved in the studies said the treatments all appear promising, although preliminary, and show how medicine is moving toward alternatives to chemotherapy.

"This is where we have to start. This is the f
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs, PARP inhibitors
2. Experimental Staph Vaccine Fails to Work, Study Finds
3. Experimental Drug May Work Against Hepatitis C
4. Experimental Alzheimers Drug Shows Promise, Study Finds
5. Experimental Vitiligo Treatment Shows Promise in Mice
6. Harmful effects of bisphenol A proved experimentally
7. Experimental agent briefly eases depression rapidly in test
8. NIH-funded trial launched to assess experimental TB drug
9. Experimental graft-vs.-host disease treatment equivalent to standard care in Phase 3 trial
10. Experimental Antidepressant Appears Quick-Acting, Safe
11. More than a third of high-risk leukemia patients respond to an experimental new drug
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Vaccine Shows Promise for Ovarian Cancer
(Date:2/28/2015)... Gerald “Solutionman” Haman surveyed over 10,000 ... to innovative thinking. “The #1 block was lack ... tools,” reports Haman, who created the Thinkubator Innovation Studio ... felt that they did not have enough time for ... to stimulate innovation. , Solutionman’s monthly “Accelerating Innovation Training” ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 March—also ... good time to remind ourselves and others that ... say Atlantic NeuroSurgical Specialists (ANS). , Concussions are ... account for 75% of TBIs. There are 1.6-3.8 ... may sound benign, but it is a brain ...
(Date:2/28/2015)... 2015 A study out of the ... therapy procedure for the treatment of a hereditary ocular ... Authored by Dr. Robert MacLaren, professor of ophthalmology ... Lancet Medical Journal on January 16, 2014 , the ... genetic disorder that mostly affects men and leads to ...
(Date:2/28/2015)... February 28, 2015 National ... outsourced sales, marketing and supply chain management for ... Botanicals, is bringing its award winning solutions for ... Botanicals’ products are specifically created to combat thinning-damaged ... BIOTA is committed to marrying science with nature ...
(Date:2/28/2015)... AZ (PRWEB) February 28, 2015 Kaylie ... and alcohol treatment center , and current student obtaining ... University, has implemented a weekly forum in psychoeducation on ... school in Flagstaff, AZ as part of her studies. ... big need for support and counseling at the high ...
Breaking Medicine News(10 mins):Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2
... test the drug manufactured by German pharmaceutical company TeGenero by ... which was designed to treat rheumatoid arthritis, leukaemia and multiple ... six men who fell seriously ill after taking part in ... like his brain was on fire. Student Nav Modi, 24, ...
... suggests that thinking that you are strong and muscles are ... Hull University research team which asked 30 subjects to do ... focused on what the muscles were doing. ,The ... which monitored levels of electrical activity in their biceps and ...
... a news study it has been shown that babies who ... have the much feared consequences and is safe. The way ... theory was researched and assessed by unconnected Nottingham researchers to ... was pioneered by controversial Stoke-based paediatrician Professor David Southall. ...
... alcohol intake seems to question the earlier studies that ... drinkers, as compared to abstainers or heavy drinkers. ... mistake in the perception of who “abstainers” are, when ... PhD, emerita professor at the University of California, San ...
... 7-day old baby was charred to death due to a short ... their joy and hopes. The incubator in which the baby was ... incident had happened due to negligence of the hospital staff while ... were saved due to prompt action of the medical staff who ...
... to the tune of ?4m or more will be allocated ... spending should take care of containing// the unhealthy trend, atleast ... up by almost 50%. ,A senior medical post ... with suicidal tendencies, according to Mr Woodward. To enable this ...
Cached Medicine News:Health News:High Spirits :Second Thoughts on the Mini Pegs 2Health News:The Face Of Indian Health Care: A World Health Day Evaluation 2Health News:The Face Of Indian Health Care: A World Health Day Evaluation 3Health News:The Face Of Indian Health Care: A World Health Day Evaluation 4
(Date:2/27/2015)... Feb. 27, 2015  Uroplasty, Inc. (NASDAQ: UPI ... markets innovative proprietary products to treat voiding dysfunctions, today ... ROTH Conference on Tuesday, March 10, 2015. Rob ... , Chief Financial Officer, will present at 4:00 p.m. ... at the conference at the Ritz Carlton in ...
(Date:2/26/2015)... -- Finesse expands office in Leicester, United Kingdom ... of its operations in Leicester , ... for customers is expected shortly afterward. With ... the current office, the new premises will double the ... Finesse to bring on more service personnel. The new ...
(Date:2/26/2015)... , Feb. 26, 2015  Today the ... The psychological and physical side effects of pain ... opioid painkillers, such as Vicodin and Oxycontin, are safer ... Americans overdose on prescription painkillers than on heroin and ... and CEO of NSC. "Yet, these medications are marketed ...
Breaking Medicine Technology:Uroplasty to Participate in the 27th Annual ROTH Conference 2New Finesse Office in United Kingdom 2National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2
... NEW YORK, Oct. 1 Keryx Biopharmaceuticals,Inc. (Nasdaq: ... the,Company,s President, will present an overview of the Company,s ... Growth Stock,Conference in New York City. Dr. Henderson,s presentation ... ET. Dr. Henderson,s presentation will be webcast live ...
... -Two 48-week Superiority Studies versus Hepsera(R) in Patients with Chronic ... Hepatitis B-,-Studies will also Assess Clevudine,s ... ... Pharmasset, Inc.,(Nasdaq: VRUS ) has commenced dosing in Phase 3 registration clinical trials,of clevudine ...
Cached Medicine Technology:Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference 2Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV 2Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV 3Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV 4Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV 5
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: